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journal homepage: www.e- jds.comCORRESPONDENCEPalatal diffuse large B-cell lymphoma
masquerading as an infiltrative bony massNon-Hodgkin lymphoma (NHL) accounts for 5% of malig-
nancies of the head and neck. In adults, diffuse large B-cell
lymphoma (DLBCL) is the most common form of NHL.1,2
Extranodal DLBCL is a rare tumor in the oral cavity,3 and
DLBCL masquerading as an infiltrative bony mass is extremely
rare. We described a rare extranodal DLBCL case and dem-
onstrated its magnetic resonance imaging (MRI) features to
help to differentiate it from other oral malignancies.
A 57-year-old man was referred to our clinic with a pro-
gressive, painful, enlarging mass of the left cheek for 2
weeks. Intraoral examination showed a firm mass with
a rubbery and ulcerative surface over the left palate and
left buccal mucosa (Fig. 1A). Radiographically, there was
a 1.6 3.4 cm, irregularly shaped, rectangular radiolucency
at the left maxillary alveolar bone (Fig. 1B). MRI revealed an
ill-demarcated, infiltrative, heterogeneously enhanced
mass (3.5  3.0  4.0 cm) in the left palatal region with
involvement of the left maxillary alveolar ridge and exten-
sion into the left anterior maxillary sinus (Fig. 1C). The
diffusion-weighted imaging (DWI) showed an obvious
restricted diffusion in the lesion (Fig. 1D). The mean
apparent diffusion coefficient (ADC) was 0.76  103 mm2/
second. Diffuse large B-cell NHL was histologically diag-
nosed. The tumor was found to contain atypical lympho-
cytes expressing CD20, bcl-2, bcl-6, and MUM1 but not CD3,
CD10, or cyclin D1 (Fig. 1E and F). The Ki-67 proliferation
rate was 90%. The patient was then referred to our hema-
tology department and cyclophosphamide, hydroxydaunor-
ubicin, Oncovin, prednisolone, and rituximab combination
chemotherapy was immediately started. The disease was
well controlled by the treatment after the clinic examina-
tion and image studies.
Generally, conventional MRI is limited in differentiating
between squamous cell carcinoma (SCC), lymphoma, and
other tumors. DWI is now used as a supportive tool for
characterizing head and neck malignant tumors. The DWI in
our case demonstrated an ADC of 0.76  103 mm2/second,
which was lower than the mean value for SCC and other
malignant tumors of the head and neck.4 In our case, the
ADC was used to rule out SCC and other oral malignancies
such as anaplastic carcinoma and metastases from an1991-7902/$36 Copyright ª 2013, Association for Dental Sciences of t
reserved.
http://dx.doi.org/10.1016/j.jds.2012.12.005unknown primary tumor having a similar presentation to
that of NHL.
We conclude that DLBCL can masquerade as an infiltrative
bonymass. This report highlights the importance of advanced
imaging in the diagnosis of this very rare form of NHL.
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Figure 1 (A) A firm mass with rubbery and ulcerative surface over the left palatal region. (B) The Panorex view shows an
irregularly shaped, rectangular radiolucency at the left maxillary alveolar bone (arrows). (C) Magnetic resonance imaging spin echo
T1-weighted (SE T1W) coronal view with contrast shows the heterogeneously enhanced mass with involvement of the left hard
palate (short thin arrow), left maxillary alveolar ridge (long thin arrow), and extension into the left anterior maxillary sinus by
breaking through the left anterior maxillary sinus wall (short white arrow). (D) Diffusion-weighted imaging axial view shows the
lesion with a low apparent diffusion coefficient (ADC) value on the ADC map in areas of interest around the mass at the same level
(arrow). The ADC was 0.76  103 mm2/second; (E) Histological examination of the tumor. Tumoral infiltration consists of atypical
lymphoid cells with large nucleus and significant nucleolus (hematoxylin and eosin, 40); (F) The tumor cells are also positive for
CD 20 (immunoperoxidase stain).
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